Appendices for "The safety of rituximab for the treatment of autoimmune blistering diseases: a systematic review"

Published: 2 February 2021| Version 1 | DOI: 10.17632/m3gbbjb2xd.1
Contributor:
Arooj Mohammed

Description

Attached are appendices for "The safety of rituximab for the treatment of autoimmune blistering diseases: a systematic review"

Files

Institutions

  • Indiana University School of Medicine

Categories

Dermatology, Rituximab, Autoimmune Disorder, Blistering

Licence